1. Home
  2. APRE vs WETH Comparison

APRE vs WETH Comparison

Compare APRE & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • WETH
  • Stock Information
  • Founded
  • APRE 2006
  • WETH 1992
  • Country
  • APRE United States
  • WETH China
  • Employees
  • APRE N/A
  • WETH N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • WETH
  • Sector
  • APRE Health Care
  • WETH
  • Exchange
  • APRE Nasdaq
  • WETH Nasdaq
  • Market Cap
  • APRE 9.4M
  • WETH 10.9M
  • IPO Year
  • APRE 2019
  • WETH N/A
  • Fundamental
  • Price
  • APRE $1.69
  • WETH $0.89
  • Analyst Decision
  • APRE Strong Buy
  • WETH
  • Analyst Count
  • APRE 1
  • WETH 0
  • Target Price
  • APRE $20.00
  • WETH N/A
  • AVG Volume (30 Days)
  • APRE 60.0K
  • WETH 82.7K
  • Earning Date
  • APRE 08-12-2025
  • WETH 08-26-2025
  • Dividend Yield
  • APRE N/A
  • WETH N/A
  • EPS Growth
  • APRE N/A
  • WETH N/A
  • EPS
  • APRE N/A
  • WETH 0.34
  • Revenue
  • APRE $841,012.00
  • WETH $41,024,264.00
  • Revenue This Year
  • APRE N/A
  • WETH N/A
  • Revenue Next Year
  • APRE N/A
  • WETH N/A
  • P/E Ratio
  • APRE N/A
  • WETH $2.59
  • Revenue Growth
  • APRE N/A
  • WETH 2.86
  • 52 Week Low
  • APRE $1.41
  • WETH $0.76
  • 52 Week High
  • APRE $5.01
  • WETH $2.96
  • Technical
  • Relative Strength Index (RSI)
  • APRE 46.79
  • WETH 50.72
  • Support Level
  • APRE $1.66
  • WETH $0.79
  • Resistance Level
  • APRE $1.79
  • WETH $0.89
  • Average True Range (ATR)
  • APRE 0.14
  • WETH 0.06
  • MACD
  • APRE -0.01
  • WETH 0.01
  • Stochastic Oscillator
  • APRE 38.89
  • WETH 57.39

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.

Share on Social Networks: